-
July 24, 2017PREVIEW
Data from more than 50 randomized controlled trials (RCTs) showed that opioid analgesic–related pharmacokinetic (PK) drug–drug interactions with various agents including antiplatelet agents,...
-
July 24, 2017PREVIEW
Results of a retrospective analysis of patients with atrial fibrillation (AF) initiated on apixaban (Eliquis—Bristol-Myers Squibb), dabigatran (Pradaxa—Boehringer Ingelheim), or rivaroxaban (...
-
July 17, 2017PREVIEW
In patients with hypertension, reductions in systolic blood pressure (SBP) to levels of 120 mm Hg to 124 mm Hg resulted in greater reductions in the risk of major cardiovascular disease (CVD),...
-
June 26, 2017PREVIEW
Elevations in serum creatinine in patients initiating angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) were associated with increased cardiorenal risks in a...
-
June 5, 2017PREVIEW
Potential drug–drug interactions with tyrosine-kinase inhibitors (TKIs) were common, with almost one-half of identified interactions classified as severe, according to results of a retrospective...
Pages
